Natures Sunshine Products anounces alliance with Fosun Pharma Nature's Sunshine Products and Shanghai Fosun Pharmaceutical announced today the signing of definitive agreements with respect to the formation of a China joint venture to market and distribute Nature's Sunshine and Synergy products in China and an investment by Fosun Pharma of approximately $46.3M in Nature's Sunshine common stock to be issued pursuant to a private placement transaction. Nature's Sunshine intends to use the net proceeds of the private placement transaction to fund its share of the China joint venture and pay a special one-time cash dividend of $1.50 per share contingent upon transaction closing. The parties anticipate closing the joint venture and private placement transaction in 3Q14, subject to customary closing conditions including the receipt of required regulatory approvals.
News For NATR From The Last 14 Days
Check below for free stories on NATR the last two weeks.